Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT05070845 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
91
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer